Therefore, ELAVL1 and PPARγ, as well as their upstream molecule AT1R, which can regulate ABCA1 expression and lipid metabolisms, are potential therapeutic targets for AMD and other macrophage-related pathogeneses. Here, ABCA1 is linked to age-related macular degeneration.